|Articles|January 21, 2016
Celltrion Adopts Medidata Clinical Cloud
Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs.
Advertisement
Seoul, Korea-based biopharmaceutical company Celltrion announced it has adopted Medidata's ClinicalCloud to provide scalable technology to its biosimilars development programs. The technologies include electronic data capture and management (Medidata Rave ®), medical coding (Medidata Coder ®) and randomization and trial supply management (Medidata Balance ®).
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
How Sponsors Can Modernize Tools to Support PhysiciansSeptember 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
